SLIDE 85 Non-NIH funding
- American Gastroenterological Association
– Supplemental Research Training Award, July 1985- June 1986, $7,500 – Industry (Glaxo) Scholar Award, "Regulation of ST-induced intestinal secretion," July 1988- June 1991, $75,000 – Research Preceptorship, Michelle R. Ritter, Summer Student, May 1989- August 1989, $1,500 – Mentor, AGA Senior Fellowship Research Award to Dr. Glen Lewis, July 1993-June 1994, $7,500. – AGA Summer Undergraduate Research Fellowship to Noeet Elitsur, ($4000), 2003 – Sponsor/Mentor: Praveen Goday 1999-2001 ($72,000) – Sponsor/Mentor: Jeffrey Rudolph, MD 2000-2002 ($72,000)
– Mentor, American Liver Foundation Award to Dr. Jane Balint, July 1994-June 1995, $7,500.
– Unrestricted Educational Grant 1999, $3,995
– Choleragard planning grant, MB Cohen PI $10,000 07/01/06-06/30/07
– "Intestinal receptor for E. coli heat-stable enterotoxin: Increased receptor density and potential role as a receptor for an intestinally active growth factor in perinatal life," July 1989- June 1990, $9,000. – Principal Investigator: Safety and Efficacy of Rice Based Oral Rehydration Solution. January 1990- March 1993, $111,120
– Regulation of STa-induced intestinal secretion.“ Trustee Award, July 1988-June 1991, $92,000 – Translational Research Initiative, $3,000 DDRC Retreat, 2002
- Cystic Fibrosis Foundation
– Expression and function of the guanylin ligand family (P978), July 1, 1995-July 1, 1996. $32,493. – First Year Clinical Fellowship Sponsor (Jeffrey Rudolph), (Rudolp97B0), 1997-98 ($30,500) – Fellowship Sponsor (Stephen Guthery), (GUTHER99B0), 1999-01 ($76,000) – Fellowship Sponsor (Valerie McLin (MCLIN01B0) 2001-3 ($84,500) – Clinical Fellowship to Nissa Erickson (ERICKS03B0)July 1, 2003-June 30, 2004 $42,000 – First Year Fellowship Award (Pasternak PASTER05B0) 7/1/05-6/30/06) 7/1/05-6/30/06 $42,000
- Marion Merrell Dow Foundation
– Transgenic models of cardiovascular disease: Guanylin overexpression in transgenic mice, 1994, $2,000 – Transgenic models of cardiovascular disease: Targeting of the guanylin gene, 1996 ($4600) – Transgenic models of cardiovascular disease: Targeting of the uroguanylin gene, 1997 ($4600)
- Mead Johnson Nutritional Group
– Development of accurate test kits for malabsorption. Project 8538. September 1994-September 1995. $24,000
- Miles Pharmaceutical Company:
– Prospective, controlled double blind randomized comparison of ciprofloxacin vs trimethoprim/sulfamethoxazole vs placebo for prevention of traveler's diarrhea. Jeff Heck, Principal Investigator; Responsible for Component III:Escherichia coli pathogen assays, February 1990- May 1992, 5% effort, $79,100 – Prospective, double-blind, randomized comparison of Ciprofloxacin 500 mg daily for 3 days vs. trimethoprim- sulfamethoxazole 160/800mg twice daily for 5 days for the empiric therapy of traveler's diarrhea. (Jeff Heck, Principal Investigator), Responsible for Component III, Escherichia coli pathogen assays, October 1992- April, 1993, 5% effort, $26,259.
- Procter and Gamble Company
– Escherichia coli pathogen assays. February 1993-February 1994. $80,000. – Efficacy of bismuth subsalicylate in decreasing stool output in children with short bowel syndrome or intestinal
- aganglionosis. September 1994- September 1995, $25,000
– Fellowship Research and Education, 1997-1998, $5,000 – Unrestricted Educational Grant, 1998, $2,400 – Bifido 624 in Prevention of Day Care Diarrhea, MB Cohen, PI 06/15/02-10/15/03 $367,000